Mylan Pharmaceuticals has won final FDA approval for its abbreviated new drug application (ANDA) for Pioglitazone tablets USP, 15mg, 30mg and 45mg. Previously, FDA has also approved the company's ANDA for Pioglitazone Hydrochloride and ...
Mylan Pharmaceuticals has introduced the generic version of Schering-Plough's Clarinex allergy medication, Desloratadine tablets, 5mg. Mylan gained final FDA approval for its abbreviated new drug application for Desloratadine Tablets, ...
Tags: Generic Clarinex Tablets, Desloratadine tablets, drug applications
Mylan, a pharmaceutical company, has introduced lamivudine film coated tablets, 150mg and 300mg, in the UK and Italy. The generic version of GlaxoSmithKline's Epivir tablets is indicated as part of antiretroviral (ARV) combination therapy ...
Tags: Generic Epivir Tablets, lamivudine film coated tablets, HIV-infected
Mylan and its subsidiary, Mylan Pharmaceuticals, have signed a settlement agreement with Pfizer, Pharmacia & Upjohn Company and Pfizer Health related to Detrol LA patent litigation. The litigation is related to Mylan Pharmaceuticals' ...
Mylan Specialty, a subsidiary of Mylan, and Pfizer have signed a licensing contract for EpiPen Injection 0.3/0.15mg in Japan. Under the license agreement, Pfizer will have the exclusive rights to market and sell EpiPen Injection ...
Tags: Epipen Injection, epinephrine auto-injector, public health
Mylan Pharmaceuticals has unveiled Doxycycline Hyclate Delayed-release (DR) Tablets USP, 150mg, a generic version of Mayne Pharma's Doryx 150mg product. The company begins the shipment of the product. Mayne Pharma's Doryx 150mg product ...
Tags: Generic Doryx Tablets, tetracycline-class antimicrobial
Mylan has unveiled Atorvastatin calcium tablets of strengths 10mg, 20mg, 40mg and 80mg in Belgium, France, the UK, Ireland and the Netherlands. The generic version of Pfizer's Lipitor is indicated to prevent cardiovascular disease and ...
Tags: Mylan, Atorvastatin calcium tablets, cardiovascular disease
Mylan Pharmaceuticals has won final FDA approval for its abbreviated new drug application for Olanzapine tablets USP, 2.5mg, 5mg, 7.5mg, 10mg, 15mg, and 20mg. The company begins the shipment of the product, which is the generic equivalent ...
Tags: Generic Zyprexa Tablets, Mylan Pharmaceuticals, new drug
Watson Pharmaceuticals has introduced Pioglitazone Hydrochloride 15mg, 30mg and 45mg tablets, a generic equivalent to Actos. The company began the shipment of the product after winning the final FDA approval. Actos is a prescription ...
Tags: Generic Version, Actos, blood sugar
Meridian Medical Technologies,a Pfizer subsidiary,and Teva have entered into a settlement agreement to resolve generic epinephrine auto-injector pending patent litigation. Under the terms of the agreement,Teva may launch a generic ...
Tags: Epinephrine Auto, Meridian, Teva, generic epinephrine auto-injector
The FDA has approved Mylan Pharmaceuticals' abbreviated new drug application (ANDA) for Clopidogrel tablets USP, 75mg and 300mg. The generic version of Sanofi-Aventis' Plavix is indicated for acute coronary syndrome and for patients with ...
Tags: Clopidogrel Tablets, Mylan Pharmaceuticals, drug application
Mylan has reached a settlement in a patent litigation suit filed by Sunovion Pharmaceuticals concerning Mylan Specialty's abbreviated new drug application for Levalbuterol Hydrochloride (HCl) Inhalation Solution, 0.31mg/3 mL, 0.63mg/3 mL, ...
Tags: Sunovion Pharmaceuticals, Medicine
Mylan Laboratories, formerly Matrix Laboratories, has gained final FDA approval for its abbreviated new drug application (ANDA) of Atorvastatin Calcium Tablets of strengths 10mg, 20mg, 40mg and 80mg. The company begins immediate shipment ...
Tags: Generic Lipitor Anda, drug application, Atorvastatin Calcium Tablets
Mylan Pharmaceuticals has won FDA approval for its abbreviated new drug application (ANDA) for Irbesartan Tablets USP, 75mg, 150mg and 300mg, the generic version of Sanofi's Avapro. The FDA has also approved the company's ANDA for ...
Tags: FDA approval, ANDA, Irbesartan Tablets
The US Food and Drug Administration (FDA) has granted final approval to Mylan Pharmaceuticals' abbreviated new drug application (ANDA) of Modafinil tablets USP,100 mg and 200 mg. Modafinil USP,100 mg and 200 mg tablets are generic ...